US Patent Issued to Enanta Pharmaceuticals on Feb. 17 for "Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,552,777, issued on Feb. 17, was assigned to Enanta Pharmaceuticals Inc. (Watertown, Mass.).

"Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof" was invented by Guoqiang Wang (Belmont, Mass.), Ruichao Shen (Belmont, Mass.), Jiang Long (Wayland, Mass.), Jun Ma (Wayland, Mass.), Xuechao Xing (Wilmington, Mass.), Yong He (Lexington, Mass.), Brett Granger (Sudbury, Mass.), Jing He (Somerville, Mass.), Bin Wang (Newton, Mass.) and Yat Sun Or (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention discloses compounds of Formula (I), or pharmaceutically acceptable salts, ester, stereoisomer, tautomer, solvat...